These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6177374)

  • 1. Purified interferon as protection against rhinovirus infection.
    Scott GM; Phillpotts RJ; Wallace J; Secher DS; Cantell K; Tyrrell DA
    Br Med J (Clin Res Ed); 1982 Jun; 284(6332):1822-5. PubMed ID: 6177374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of human fibroblast interferon to protect against rhinovirus infection.
    Scott GM; Reed S; Cartwright T; Tyrrell D
    Arch Virol; 1980; 65(2):135-9. PubMed ID: 6158933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds.
    Farr BM; Gwaltney JM; Adams KF; Hayden FG
    Antimicrob Agents Chemother; 1984 Jul; 26(1):31-4. PubMed ID: 6089652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds.
    Hayden FG; Kaiser DL; Albrecht JK
    Antimicrob Agents Chemother; 1988 Feb; 32(2):224-30. PubMed ID: 2834996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial.
    Turner RB; Wecker MT; Pohl G; Witek TJ; McNally E; St George R; Winther B; Hayden FG
    JAMA; 1999 May; 281(19):1797-804. PubMed ID: 10340366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ineffectiveness of recombinant interferon-beta serine nasal drops for prophylaxis of natural colds.
    Sperber SJ; Levine PA; Sorrentino JV; Riker DK; Hayden FG
    J Infect Dis; 1989 Oct; 160(4):700-5. PubMed ID: 2551976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human interferon-gamma as prophylaxis against rhinovirus colds in volunteers.
    Higgins PG; al-Nakib W; Barrow GI; Tyrrell DA
    J Interferon Res; 1988 Oct; 8(5):591-6. PubMed ID: 2853194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli.
    Scott GM; Phillpotts RJ; Wallace J; Gauci CL; Greiner J; Tyrrell DA
    Lancet; 1982 Jul; 2(8291):186-8. PubMed ID: 6177991
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon.
    Hayden FG; Albrecht JK; Kaiser DL; Gwaltney JM
    N Engl J Med; 1986 Jan; 314(2):71-5. PubMed ID: 3001519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds.
    Turner RB
    Clin Infect Dis; 2001 Dec; 33(11):1865-70. PubMed ID: 11692298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on the nasal mucosa of upper respiratory viruses (common cold).
    Winther B
    Dan Med Bull; 1994 Apr; 41(2):193-204. PubMed ID: 8039434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal chalcone, Ro 09-0410, as prophylaxis against rhinovirus infection in human volunteers.
    Al-Nakib W; Higgins PG; Barrow I; Tyrrell DA; Lenox-Smith I; Ishitsuka H
    J Antimicrob Chemother; 1987 Dec; 20(6):887-92. PubMed ID: 3326874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837).
    al-Nakib W; Higgins PG; Barrow GI; Tyrrell DA; Andries K; Vanden Bussche G; Taylor N; Janssen PA
    Antimicrob Agents Chemother; 1989 Apr; 33(4):522-5. PubMed ID: 2543283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal lymphoblastoid interferon ("Wellferon") prophylaxis against rhinovirus and influenza virus in volunteers.
    Phillpotts RJ; Higgins PG; Willman JS; Tyrrell DA; Freestone DS; Shepherd WM
    J Interferon Res; 1984; 4(4):535-41. PubMed ID: 6094684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults.
    Sperber SJ; Levine PA; Innes DJ; Mills SE; Hayden FG
    J Infect Dis; 1988 Jul; 158(1):166-75. PubMed ID: 2839579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness.
    Hayden FG; Gwaltney JM
    J Infect Dis; 1983 Sep; 148(3):543-50. PubMed ID: 6311914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trials of interferon in respiratory infections of man.
    Tyrrell DA
    Tex Rep Biol Med; 1977; 35():486-90. PubMed ID: 358470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of an interferon inducer, N,N-dihexadecyl-m-xylylenediamine, on rhinovirus challenge in humans.
    Douglas RG; Waldman RH; Betts RF; Ganguly R
    Antimicrob Agents Chemother; 1979 Feb; 15(2):269-72. PubMed ID: 371545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of experimental rhinovirus colds by receptor blockade.
    Hayden FG; Gwaltney JM; Colonno RJ
    Antiviral Res; 1988 Jul; 9(4):233-47. PubMed ID: 2849376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-beta ser as prophylaxis against experimental rhinovirus infection in volunteers.
    Higgins PG; Al-Nakib W; Willman J; Tyrrell DA
    J Interferon Res; 1986 Apr; 6(2):153-9. PubMed ID: 3014018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.